PAR PHARMACEUTICAL COMPANIES, INC.

Inactive Instrument

Par Pharmaceutical Companies, Inc. Stock

Stocks

US69888P1066

Pharmaceuticals

End-of-day quote NYSE Other stock markets
- ^USD	-

15-05-18

Endo : pushes further into generics with $8 billion Par Pharma buy

RE

on all subscriptions*

Enjoy this offer

* See conditions under "Our services"

Latest news : Par Pharmaceutical Companies, Inc.

15-05-18

Endo : pushes further into generics with $8 billion Par Pharma buy

RE

Press Releases: Par Pharmaceutical Companies, Inc.

13-01-18	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Generic Lamictal® XR	PU
13-01-02	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Rizatriptan Benzoate Tablets	PU
12-12-05	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Generic Atacand HCT®	PU
12-11-30	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Generic Symbyax®	PU
12-10-29	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Acquires Rights To Market And Distribute Generic Seroquel Xr® In The U.S.	PU

More press releases

News in other languages: Par Pharmaceutical Companies, Inc.

15-05-18	Endo rachète Par Parma pour créer un géant des génériques
15-05-18	Altera : Wall Street débute la semaine sans tendance
15-05-18	Wall Street débute la semaine sans tendance
15-05-18	Accenture : Les valeurs à suivre sur les marchés américains
15-05-18	Endo : rachète le génériqueur Par Pharmaceuticals

Managers and Directors: Par Pharmaceutical Companies, Inc.

Manager	Title	Age	Since
Paul Campanelli CEO	Chief Executive Officer	64	2012-08-31

Director	Title	Age	Since
Paul Campanelli BRD	Director/Board Member	64	2012-08-31

Generic Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	SUN PHARMACEUTICAL INDUSTRIES LTD.	+0.73%	+1.51%	+9.89%	+81.01%	45.7B
	OTSUKA HOLDINGS CO., LTD.	+2.03%	+2.97%	+46.99%	+92.04%	34B
	CIPLA LIMITED	-1.86%	-2.15%	-10.38%	+33.24%	11.73B
	ZYDUS LIFESCIENCES LIMITED	-1.91%	-3.71%	+10.44%	+90.85%	11.48B
	KRKA, D. D.	+1.33%	+3.12%	+39.68%	+130.57%	9.28B
	GEDEON RICHTER	-0.76%	0.00%	+16.91%	+41.56%	7.21B
	ONO PHARMACEUTICAL CO., LTD.	-0.42%	+1.15%	+43.74%	-18.24%	6.62B
	GLENMARK PHARMACEUTICALS LIMITED	-1.15%	-0.58%	+28.96%	+232.92%	6.44B
	SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-3.10%	-3.56%	-43.65%	-7.24%	5.01B
	Average	-0.58%	-0.02%	+15.84%	+75.19%	15.27B
	Weighted average by Cap.	+0.28%	+0.51%	+20.33%	+80.88%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!